Skip to main content

Table 2 Multiplicity of colonic dysplastic foci and tumors induced by a CMNC in combination with DSS

From: o-Aminoazotoluene, 7,12-dimethylbenz[a]anthracene, and N-ethyl-N-nitrosourea, which are mutagenic but not carcinogenic in the colon, rapidly induce colonic tumors in mice with dextran sulfate sodium-induced colitis

Treatment

Dysplasia

Adenoma

Adenocarcinoma

Tumora

Non-treatment

0 ± 0

0 ± 0

0 ± 0

0 ± 0

Vehicleb + 4% DSS

0 ± 0

0 ± 0

0 ± 0

0 ± 0

AAT (125 mg/kg/day)

0 ± 0

0 ± 0

0 ± 0

0 ± 0

AAT (125 mg/kg/day) + 4% DSS

0.9 ± 0.6***

3.8 ± 1.2***

4.1 ± 1.7***

7.9 ± 2.0***

DMBA (25 mg/kg/day)

0 ± 0

0 ± 0

0 ± 0

0 ± 0

DMBA (25 mg/kg/day) + 4% DSS

1.0 ± 1.1**

1.5 ± 2.0*

1.5 ± 1.6**

3.0 ± 1.9***

ENU (11 mg/kg/day)

0 ± 0

0 ± 0

0 ± 0

0 ± 0

ENU (11 mg/kg/day) + 4% DSS

1.6 ± 0.5***

4.9 ± 1.9***

3.7 ± 1.5***

8.6 ± 1.1***

  1. Multiplicity indicates the number of dysplasias, adenomas, or adenocarcinomas per mouse, mean ± standard deviation
  2. CMNC; colon-mutagenic non-carcinogen
  3. a: adenoma + adenocarcinoma
  4. b: water for injection for 7 mice and salad oil for 6 mice
  5. *, **, ***; significantly different from the DSS alone group at P < 0.1, 0.05, 0.01 in the Welch’s t-test